Education
About Us
Working with TipRanks
Follow Us
Uscom Limited (AU:UCM)
ASX:UCM
UCM Stock Chart & Stats
AU$0.01
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.01
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.06
Previous CloseN/A
Volume140.68K
Average Volume (3M)3.23K
Market Cap
AU$3.12M
Enterprise ValueAU$5.30M
Total Cash (Recent Filing)AU$966.66K
Total Debt (Recent Filing)AU$2.26M
Price to Earnings (P/E)―
Beta-1.81
Next Earnings
Feb 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding260,147,130
10 Day Avg. Volume0
30 Day Avg. Volume3,233
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)-76.24
Price to Sales (P/S)1.13
P/FCF Ratio-1.07
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Sell
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Uscom Limited News
UCM FAQ
What was Uscom Limited’s price range in the past 12 months?
Uscom Limited lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.
What is Uscom Limited’s market cap?
Uscom Limited’s market cap is AU$3.12M.
When is Uscom Limited’s upcoming earnings report date?
Uscom Limited’s upcoming earnings report date is Feb 25, 2026 which is in 61 days.
How were Uscom Limited’s earnings last quarter?
Uscom Limited released its earnings results on Aug 29, 2025. The company reported -AU$0.008 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.008.
Is Uscom Limited overvalued?
According to Wall Street analysts Uscom Limited’s price is currently Overvalued.
Does Uscom Limited pay dividends?
Uscom Limited does not currently pay dividends.
What is Uscom Limited’s EPS estimate?
Uscom Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Uscom Limited have?
Uscom Limited has 260,147,130 shares outstanding.
What happened to Uscom Limited’s price movement after its last earnings report?
Uscom Limited reported an EPS of -AU$0.008 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Uscom Limited?
Currently, no hedge funds are holding shares in AU:UCM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Uscom Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Neutral
AU:UCM Sentiment 50%
Sector Average ―
Sector Average ―
Technicals
SMA
Negative
20 days / 200 days
Momentum
0.00%
12-Months-Change
Fundamentals
Return on Equity
-218.52%
Trailing 12-Months
Asset Growth
-36.74%
Trailing 12-Months
Company Description
Uscom Limited
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company also provides the SpiroSonic AIR, a digital multipath ultrasonic spirometer with a viral disinfection system for the elimination of COVID and tuberculosis; and respiratory devices. It serves hospitals and other medical care locations through a network of distribution partners. The company was formerly known as Uscom Pty Limited and changed its name to Uscom Limited in October 2003. The company was incorporated in 1999 and is headquartered in Sydney, Australia.
Technical Analysis
HeraMED Ltd.
―
Atomo Diagnostics Ltd.
―
Adherium Ltd.
―
InhaleRx Limited
―
Control Bionics Ltd.
―
Options Prices
Currently, No data available
---